Forian Inc

Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The firm provides a suite of SaaS solution, as well as cannabis dispensaries. The company was founded by Max C. Wygod and Adam Dublin on October 15, 2020 and is headquartered in Newtown, PA.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Forian Inc reports strong revenue growth post-divestiture, eyes profitability

Forian Inc showcased strong revenue growth in Q4 2022 and full year 2022, driven by the divestiture of cannabis software assets and focus on healthcare information.
While facing net losses, the company exceeded revenue guidance and has a solid contracted backlog for 2023, aiming for positive adjusted EBITDA in the latter part of the year.
Challenges include ongoing profitability concerns and the need for operational efficiency improvements, but opportunities lie in expanding the healthcare information business and capturing market share.
Overall, Forian's strategic shifts have positioned the company for growth and profitability, with a clear focus on healthcare technology and a strong revenue outlook for 2023.

Forian Inc reports strong Q1 earnings and eyes future growth

Forian Inc delivered robust financial performance in Q1 2023, with significant revenue growth and improved net income.
While challenges persist, the company's focus on healthcare analytics and strong balance sheet sets a solid foundation for future growth.
Opportunities lie ahead for Forian to leverage its expertise and financial stability for sustained expansion and strategic initiatives.

Forian Inc excels in Q2 2023, eyes expansion and acquisitions

Forian Inc's Q2 2023 performance reflects robust revenue growth and improved financial metrics, positioning the company for future success.
While challenges like net losses persist, strategic initiatives to enhance operational efficiency and profitability are underway.
Opportunities for expansion and acquisitions, coupled with a strong balance sheet, underscore Forian's potential for sustained growth and market leadership.

Forian Inc reports robust Q3 performance and eyes growth opportunities

Forian Inc delivered a strong third-quarter performance with revenue growth and improved profitability. The company's strategic wins and focus on data science-based offerings position it well for future growth.
While challenges such as market risks and customer acquisition impact exist, Forian's financial strength and opportunities for revenue growth and market expansion provide a positive outlook.
With a solid financial position, plans to capitalize on growth opportunities, and a commitment to innovation, Forian is poised to navigate challenges and leverage opportunities in the health care information sector.

Forian Inc reports solid Q4 earnings and projects growth in 2024

Forian Inc ended 2023 on a positive note, showcasing strong financial performance and strategic advancements. The company is poised for continued growth in 2024 despite market challenges, leveraging its data-driven ecosystem and product innovations.

Forian Inc reports stable Q1 performance and launches innovative products

Forian Inc's Q1 2024 performance showed stability in revenues, improved EBITDA, and strategic growth initiatives.
The company faces challenges in revenue growth and profitability but has opportunities in market expansion and product innovation.
By focusing on operational efficiency, new client acquisition, and corporate development, Forian Inc aims for sustained growth and profitability.

Forian Inc reports steady Q2 performance amidst market disruptions

Forian Inc's Q2 2024 performance was steady with flat revenue and a net loss, facing challenges from funding issues and data disruptions.
Despite these challenges, the company remains confident, plans to invest in assets, and sees opportunities for growth.
Market disruptions led to revised revenue outlook, but Forian's financial stability and strategic focus position it for future success.

Forian Inc. reports steady Q3 performance and acquires Kyber Data Science

Forian Inc. demonstrates resilience with steady financial performance and strategic acquisitions to bolster its market position and data analytics capabilities.
Challenges from past customer losses and data disruptions are being addressed through ongoing efforts, while opportunities for growth and innovation are actively pursued.
Investors should note Forian's commitment to enhancing shareholder value through strategic initiatives and its confidence in maintaining competitiveness in the market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Forian Inc. (NASDAQ:FORA) said it has entered into a securities purchase agreement with a select group of institutional and accredited investors to raise gross proceeds of $12,000,000 resulting from the sale of 1,191,743 shares of its common stock at an average purchase price equal to $10.21 per share.  The company, a provider of software and technology-enabled services for the healthcare and cannabis industries, said it did not engage a placement agent in connection with the private investment in public equity (PIPE) financing.

Forian enters securities purchase agreement with select group of institutional and accredited investors to raise gross proceeds of $12M

NEWTOWN, Pa., April 12, 2021 /PRNewswire/ -- Forian Inc. (Nasdaq:FORA), a provider of software and technology-enabled services for the healthcare and cannabis industries, announced today that it has entered into a securities purchase agreement with a select group of institutional and accredited investors to raise gross proceeds of $12,000,000 resulting from the sale of 1,191,743 shares of its common stock at an average purchase price equal to $10.21 per share.

Forian Inc. Announces $12 Million Private Placement of Common Stock

News for Forian Inc Stock (FORA)